Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Biovail acquires worldwide rights to tetrabenazine from Cambridge Laboratories

May 21, 2009

Novel mGluR5 receptor antagonists emerge from AstraZeneca R&D

May 20, 2009

Shire presents guanfacine study results in ADHD

May 20, 2009

A.P. Pharma submits NDA to FDA for APF-530 in CINV

May 20, 2009

FDA approves Johnson & Johnson's antipsychotic Risperdal Consta for bipolar I disorder

May 20, 2009

Sepracor withdraws marketing authorization application for Lunivia (eszopiclone)

May 19, 2009

Suven Life Sciences claims novel 5-HT6 receptor ligands as anxiolytics

May 19, 2009

Cadence submits NDA to FDA for Acetavance for acute pain and fever in adults and children

May 19, 2009

Allergan claims novel sphingosine 1-phosphate receptor ligands for the treatment of pain

May 18, 2009

Positive clinical results reported for Archimedes' NasalFent fentanyl nasal spray for cancer pain

May 18, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...